Idiopathic Pulmonary Fibrosis  >>  pamrevlumab (FG-3019)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pamrevlumab (FG-3019) / FibroGen
NCT00074698: Safety and Tolerability Study of FG-3019 in Participants With Idiopathic Pulmonary Fibrosis

Completed
1
21
US
FG-3019, Recombinant human monoclonal antibody
FibroGen
Idiopathic Pulmonary Fibrosis
 
05/04

Download Options